patients home
product info
safety
prescribing information
elan pain information center
prialt.com
Search
Go
Advanced
Search
Look In:
All
Product Information
Literature
Keywords:
Select a category and enter values in the fields to limit your search. You can further refine your search by using the wildcard character (*) and Boolean operators (AND, OR). For detailed instructions on using Search, click Help
Search
Reset
Help
Important Safety Considerations
Warning: Severe psychiatric symptoms and neurological impairment may occur during treatment with PRIALT. Patients with a pre-existing history of psychosis should not be treated with PRIALT. All patients should be monitored frequently for evidence of cognitive impairment, hallucinations, or changes in mood or consciousness. PRIALT therapy can be interrupted or discontinued abruptly without evidence of withdrawal effects in the event of serious neurological or psychiatric signs or symptoms.
PRIALT is for use only in the Medtronic SynchroMed
®
EL,
SynchroMed
®
II Infusion System and the CADD-Micro ambulatory infusion pump.
This website is intended for residents of the United States, Puerto Rico, and US Territories.
PRIALT
®
is a registered trademark and
is a trademark of Elan Pharmaceuticals, Inc.
SynchroMed
®
is a registered trademark of Medtronic, Inc.